Whether any cases of human prion disease were reported (a) in each of the past three financial years and/or (b) since 1 April 2017; if so, (i) what number of cases were reported, (ii) where was the disease reported, (iii) what was the cause in each case and (iv) what preventative action was taken to prevent further transmission of the disease in each case?